133 related articles for article (PubMed ID: 22770934)
1. Clinical and echocardiographic correlates of elevated troponin in amyloid light-chain cardiac amyloidosis.
Apridonidze T; Steingart RM; Comenzo RL; Hoffman J; Goldsmith Y; Bella JN; Landau H; Liu JE
Am J Cardiol; 2012 Oct; 110(8):1180-4. PubMed ID: 22770934
[TBL] [Abstract][Full Text] [Related]
2. Prognosis of Light Chain Amyloidosis With Preserved LVEF: Added Value of 2D Speckle-Tracking Echocardiography to the Current Prognostic Staging System.
Barros-Gomes S; Williams B; Nhola LF; Grogan M; Maalouf JF; Dispenzieri A; Pellikka PA; Villarraga HR
JACC Cardiovasc Imaging; 2017 Apr; 10(4):398-407. PubMed ID: 27639764
[TBL] [Abstract][Full Text] [Related]
3. Utility of B-Type Natriuretic Peptide for Detecting Cardiac Involvement in Immunoglobulin Amyloidosis.
Kimishima Y; Yoshihisa A; Kiko T; Yokokawa T; Miyata-Tatsumi M; Misaka T; Oikawa M; Kobayashi A; Takeishi Y
Int Heart J; 2019 Sep; 60(5):1106-1112. PubMed ID: 31484874
[TBL] [Abstract][Full Text] [Related]
4. Noninvasive risk stratification of patients with transthyretin amyloidosis.
Kristen AV; Scherer K; Buss S; aus dem Siepen F; Haufe S; Bauer R; Hinderhofer K; Giannitsis E; Hardt S; Haberkorn U; Katus HA; Steen H
JACC Cardiovasc Imaging; 2014 May; 7(5):502-10. PubMed ID: 24726252
[TBL] [Abstract][Full Text] [Related]
5. Independent predictors of survival in primary systemic (Al) amyloidosis, including cardiac biomarkers and left ventricular strain imaging: an observational cohort study.
Bellavia D; Pellikka PA; Al-Zahrani GB; Abraham TP; Dispenzieri A; Miyazaki C; Lacy M; Scott CG; Oh JK; Miller FA
J Am Soc Echocardiogr; 2010 Jun; 23(6):643-52. PubMed ID: 20434879
[TBL] [Abstract][Full Text] [Related]
6. Osteopontin: a novel predictor of survival in patients with systemic light-chain amyloidosis.
Kristen AV; Rosenberg M; Lindenmaier D; Merkle C; Steen H; Andre F; Schönland SO; Schnabel PA; Schuster T; Röcken C; Giannitsis E; Katus HA; Frey N
Amyloid; 2014 Sep; 21(3):202-10. PubMed ID: 25007036
[TBL] [Abstract][Full Text] [Related]
7. Clinical correlates and prognostic values of pseudoinfarction in cardiac light-chain amyloidosis.
Zhao L; Li J; Tian Z; Fang Q
J Cardiol; 2016 Nov; 68(5):426-430. PubMed ID: 26685729
[TBL] [Abstract][Full Text] [Related]
8. Comparison of functional status, electrocardiographic, and echocardiographic parameters to mortality in endomyocardial-biopsy proven cardiac amyloidosis.
Austin BA; Duffy B; Tan C; Rodriguez ER; Starling RC; Desai MY
Am J Cardiol; 2009 May; 103(10):1429-33. PubMed ID: 19427441
[TBL] [Abstract][Full Text] [Related]
9. Longitudinal left ventricular function for prediction of survival in systemic light-chain amyloidosis: incremental value compared with clinical and biochemical markers.
Buss SJ; Emami M; Mereles D; Korosoglou G; Kristen AV; Voss A; Schellberg D; Zugck C; Galuschky C; Giannitsis E; Hegenbart U; Ho AD; Katus HA; Schonland SO; Hardt SE
J Am Coll Cardiol; 2012 Sep; 60(12):1067-76. PubMed ID: 22883634
[TBL] [Abstract][Full Text] [Related]
10. Synergistic Utility of Brain Natriuretic Peptide and Left Ventricular Global Longitudinal Strain in Asymptomatic Patients With Significant Primary Mitral Regurgitation and Preserved Systolic Function Undergoing Mitral Valve Surgery.
Alashi A; Mentias A; Patel K; Gillinov AM; Sabik JF; Popović ZB; Mihaljevic T; Suri RM; Rodriguez LL; Svensson LG; Griffin BP; Desai MY
Circ Cardiovasc Imaging; 2016 Jul; 9(7):. PubMed ID: 27342145
[TBL] [Abstract][Full Text] [Related]
11. Role of cardiac magnetic resonance imaging in the detection of cardiac amyloidosis.
Syed IS; Glockner JF; Feng D; Araoz PA; Martinez MW; Edwards WD; Gertz MA; Dispenzieri A; Oh JK; Bellavia D; Tajik AJ; Grogan M
JACC Cardiovasc Imaging; 2010 Feb; 3(2):155-64. PubMed ID: 20159642
[TBL] [Abstract][Full Text] [Related]
12. Echocardiographic and biohumoral characteristics in patients with AL and TTR amyloidosis at diagnosis.
Cappelli F; Baldasseroni S; Bergesio F; Perlini S; Salinaro F; Padeletti L; Attanà P; Paoletti Perini A; Moggi Pignone A; Grifoni E; Fabbri A; Marchionni N; Gensini GF; Perfetto F
Clin Cardiol; 2015 Feb; 38(2):69-75. PubMed ID: 25645201
[TBL] [Abstract][Full Text] [Related]
13. Doppler index combining systolic and diastolic myocardial performance: clinical value in cardiac amyloidosis.
Tei C; Dujardin KS; Hodge DO; Kyle RA; Tajik AJ; Seward JB
J Am Coll Cardiol; 1996 Sep; 28(3):658-64. PubMed ID: 8772753
[TBL] [Abstract][Full Text] [Related]
14. Predictors of cardiac involvement and survival in patients with primary systemic light-chain amyloidosis: roles of the clinical, chemical, and 3-D speckle tracking echocardiography parameters.
Lei C; Zhu X; Hsi DH; Wang J; Zuo L; Ta S; Yang Q; Xu L; Zhao X; Wang Y; Sun S; Liu L
BMC Cardiovasc Disord; 2021 Jan; 21(1):43. PubMed ID: 33478398
[TBL] [Abstract][Full Text] [Related]
15. Subtype-Specific Interactions and Prognosis in Cardiac Amyloidosis.
Sperry BW; Vranian MN; Hachamovitch R; Joshi H; Ikram A; Phelan D; Hanna M
J Am Heart Assoc; 2016 Mar; 5(3):e002877. PubMed ID: 27013539
[TBL] [Abstract][Full Text] [Related]
16. Impaired right ventricular function as a predictor of early mortality in patients with light‑ chain cardiac amyloidosis assessed in a cardiology department.
Szczygieł JA; Wieczorek PZ; Drozd-Sokołowska J; Michałek P; Mazurkiewicz Ł; Legatowicz-Koprowska M; Walczak E; Jędrzejczak WW; Dwilewicz-Trojaczek J; Grzybowski J
Pol Arch Intern Med; 2017 Dec; 127(12):854-864. PubMed ID: 29112180
[TBL] [Abstract][Full Text] [Related]
17. Cardiac biomarkers are prognostic in systemic light chain amyloidosis with no cardiac involvement by standard criteria.
Sharpley FA; Fontana M; Martinez-Naharro A; Manwani R; Mahmood S; Sachchithanantham S; Lachmann HJ; Gillmore JD; Whelan CJ; Hawkins PN; Wechalekar AD
Haematologica; 2020 May; 105(5):1405-1413. PubMed ID: 31399529
[TBL] [Abstract][Full Text] [Related]
18. Senile systemic amyloidosis: clinical features at presentation and outcome.
Pinney JH; Whelan CJ; Petrie A; Dungu J; Banypersad SM; Sattianayagam P; Wechalekar A; Gibbs SD; Venner CP; Wassef N; McCarthy CA; Gilbertson JA; Rowczenio D; Hawkins PN; Gillmore JD; Lachmann HJ
J Am Heart Assoc; 2013 Apr; 2(2):e000098. PubMed ID: 23608605
[TBL] [Abstract][Full Text] [Related]
19. Comparison of right ventricular longitudinal strain imaging, tricuspid annular plane systolic excursion, and cardiac biomarkers for early diagnosis of cardiac involvement and risk stratification in primary systematic (AL) amyloidosis: a 5-year cohort study.
Bellavia D; Pellikka PA; Dispenzieri A; Scott CG; Al-Zahrani GB; Grogan M; Pitrolo F; Oh JK; Miller FA
Eur Heart J Cardiovasc Imaging; 2012 Aug; 13(8):680-9. PubMed ID: 22307866
[TBL] [Abstract][Full Text] [Related]
20. Impact of genotype and phenotype on cardiac biomarkers in patients with transthyretin amyloidosis - Report from the Transthyretin Amyloidosis Outcome Survey (THAOS).
Kristen AV; Maurer MS; Rapezzi C; Mundayat R; Suhr OB; Damy T;
PLoS One; 2017; 12(4):e0173086. PubMed ID: 28384285
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]